GB1531047A - Steroid sulphoxides and their preparation - Google Patents
Steroid sulphoxides and their preparationInfo
- Publication number
- GB1531047A GB1531047A GB45413/76A GB4541376A GB1531047A GB 1531047 A GB1531047 A GB 1531047A GB 45413/76 A GB45413/76 A GB 45413/76A GB 4541376 A GB4541376 A GB 4541376A GB 1531047 A GB1531047 A GB 1531047A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- phenyl
- formula
- double bond
- aralkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003431 steroids Chemical class 0.000 title abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 abstract 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 abstract 2
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 abstract 2
- 229960005471 androstenedione Drugs 0.000 abstract 2
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005265 dialkylamine group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- JWUKZUIGOJBEPC-UHFFFAOYSA-N phenyl thiohypochlorite Chemical compound ClSC1=CC=CC=C1 JWUKZUIGOJBEPC-UHFFFAOYSA-N 0.000 abstract 1
- -1 phenylsulphonyl Chemical group 0.000 abstract 1
- 125000005544 phthalimido group Chemical group 0.000 abstract 1
- 239000003880 polar aprotic solvent Substances 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
- 229960003604 testosterone Drugs 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
- C07J7/0075—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified substituted in position 17 alfa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Electromechanical Clocks (AREA)
- Electric Clocks (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/632,671 US4041055A (en) | 1975-11-17 | 1975-11-17 | Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1531047A true GB1531047A (en) | 1978-11-01 |
Family
ID=24536447
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9335/78A Expired GB1531048A (en) | 1975-11-17 | 1976-11-02 | 17alpha-hydroxy-20-substituted-delta20-steroids |
| GB9337/78A Expired GB1531050A (en) | 1975-11-17 | 1976-11-02 | Preparation of corticoids |
| GB45413/76A Expired GB1531047A (en) | 1975-11-17 | 1976-11-02 | Steroid sulphoxides and their preparation |
| GB9336/78A Expired GB1531049A (en) | 1975-11-17 | 1976-11-02 | Preparation of 21-halosteroids |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9335/78A Expired GB1531048A (en) | 1975-11-17 | 1976-11-02 | 17alpha-hydroxy-20-substituted-delta20-steroids |
| GB9337/78A Expired GB1531050A (en) | 1975-11-17 | 1976-11-02 | Preparation of corticoids |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9336/78A Expired GB1531049A (en) | 1975-11-17 | 1976-11-02 | Preparation of 21-halosteroids |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4041055A (enExample) |
| JP (3) | JPS5262265A (enExample) |
| CH (2) | CH636362A5 (enExample) |
| DE (1) | DE2649753C2 (enExample) |
| FR (2) | FR2351997A1 (enExample) |
| GB (4) | GB1531048A (enExample) |
| HU (8) | HU178128B (enExample) |
| IE (1) | IE44548B1 (enExample) |
| IL (3) | IL50787A (enExample) |
| MX (1) | MX4328E (enExample) |
| NL (1) | NL170420C (enExample) |
| PL (3) | PL119050B1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2146334A (en) * | 1981-05-18 | 1985-04-17 | Upjohn Co | Steroid 21-sulfoxides |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4041055A (en) * | 1975-11-17 | 1977-08-09 | The Upjohn Company | Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes |
| US4216159A (en) * | 1978-05-25 | 1980-08-05 | The Upjohn Company | Synthesis of 16-unsaturated pregnanes from 17-keto steroids |
| US4336200A (en) * | 1980-01-31 | 1982-06-22 | The Upjohn Company | 17α-Acyloxy-5β-corticoids |
| FR2486947A1 (fr) * | 1980-07-15 | 1982-01-22 | Roussel Uclaf | Nouveaux derives steroides 20-isonitriles 17(20) insatures, leur procede de preparation et leur application a la preparation des steroides 17a-hydroxy 20-ceto |
| HU183397B (en) * | 1981-04-16 | 1984-04-28 | Richter Gedeon Vegyeszet | Process for preparing 17alpha-hydroxy-pregn-4-ene-3,20-dione derivatives |
| US4401599A (en) * | 1981-05-18 | 1983-08-30 | The Upjohn Company | Preparation of 21-halo steroids |
| US4342702A (en) * | 1981-05-18 | 1982-08-03 | The Upjohn Company | Metallated halogenated acetylene corticoid synthesis |
| US4404142A (en) * | 1981-05-18 | 1983-09-13 | The Upjohn Company | Preparation of corticoids from 17-keto steroids |
| US4412955A (en) * | 1981-05-18 | 1983-11-01 | The Upjohn Company | Preparation of corticoids from 17-keto steroids |
| US4411835A (en) * | 1981-05-18 | 1983-10-25 | The Upjohn Company | Preparation of corticoids from 17-keto steroids |
| US4383947A (en) * | 1981-07-24 | 1983-05-17 | The Upjohn Company | Introduction of a fluorine atom |
| US4524134A (en) * | 1982-07-30 | 1985-06-18 | The Upjohn Company | Process for preparing 1,2-dehydro steroids |
| DE3322120A1 (de) * | 1982-07-30 | 1984-02-02 | The Upjohn Co., 49001 Kalamazoo, Mich. | Verfahren zur umwandlung von 1,2-gesaettigten 3-ketosteroiden in 1,2-dehydrosteroide |
| EP0179496A1 (en) * | 1982-09-20 | 1986-04-30 | The Upjohn Company | 16-Sulfinylmethyl-steroids, their preparation and use |
| US4704358A (en) * | 1982-10-25 | 1987-11-03 | The Upjohn Company | Δ1 -dehydrogenation with heat or air-dried B. cyclooxidans |
| US4684610A (en) * | 1983-03-15 | 1987-08-04 | The Upjohn Company | Process for converting 1,2-saturated steroids to 1,2-dehydro steroids |
| US4749649A (en) * | 1983-05-16 | 1988-06-07 | The Upjohn Company | Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen |
| US4614621A (en) * | 1984-04-20 | 1986-09-30 | The Upjohn Company | Ethynylation of 16-methylene-17-keto steroids |
| US4618456A (en) * | 1984-03-20 | 1986-10-21 | The Upjohn Company | Ethynylation of 16-methyl-17-keto steroids |
| US4831131A (en) * | 1984-02-03 | 1989-05-16 | The Upjohn Company | 11β,17α-Dihydroxy-17β-cyano-androstanes |
| US4548748A (en) * | 1984-02-03 | 1985-10-22 | The Upjohn Company | Cyanohydrin process |
| US4585590A (en) * | 1984-02-03 | 1986-04-29 | The Upjohn Company | Cyanohydrin process |
| US4500461A (en) * | 1984-02-03 | 1985-02-19 | The Upjohn Company | Cyanohydrin process |
| US4530795A (en) * | 1984-02-27 | 1985-07-23 | The Upjohn Company | Process for preparation of 16 α-methyl corticoids from Δ16 -steroids |
| US4600538A (en) * | 1984-08-02 | 1986-07-15 | The Upjohn Company | Corticosteroids from 17-keto steroids via 20-cyano-Δ17 (20)-pregnanes |
| US4613463A (en) * | 1984-11-01 | 1986-09-23 | The Upjohn Company | Process and intermediates for the preparation of 17 alphahydroxyprogesterones and corticoids from an enol steroid |
| US5506354A (en) * | 1985-09-12 | 1996-04-09 | The Upjohn Company | Imidazolylpiperazinyl steroids |
| US5099019A (en) * | 1985-09-12 | 1992-03-24 | Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
| USRE35053E (en) * | 1985-09-12 | 1995-10-10 | The Upjohn Company | Amines useful in producing pharmaceutically active CNS compounds |
| US4910191A (en) * | 1988-06-28 | 1990-03-20 | Merrell Dow Pharmaceuticals Inc. | 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
| US5972922A (en) * | 1990-06-11 | 1999-10-26 | Alcon Laboratories, Inc. | Steroids which inhibit angiogenesis |
| AU657690B2 (en) * | 1990-06-11 | 1995-03-23 | Alcon Laboratories, Inc. | Steroids which inhibit angiogenesis |
| CA2123405C (en) * | 1991-11-22 | 2008-01-15 | Abbot F. Clark | Angiostatic steroids |
| RU2172173C2 (ru) * | 1999-07-21 | 2001-08-20 | Научно-исследовательский институт наркологии МЗ РФ | 17α,21-ДИАЦЕТАТ 17α,21-ДИГИДРОКСИПРЕГН-4-ЕН-3,20-ДИОН, ОБЛАДАЮЩИЙ АНТИАЛКОГОЛЬНОЙ И АДАПТОГЕННОЙ АКТИВНОСТЬЮ |
| RU2156255C1 (ru) * | 1999-12-08 | 2000-09-20 | Андрюшина Валентина Александровна | Способ получения прегнанов |
| US20040023935A1 (en) * | 2002-08-02 | 2004-02-05 | Dey, L.P. | Inhalation compositions, methods of use thereof, and process for preparation of same |
| US20040109826A1 (en) * | 2002-12-06 | 2004-06-10 | Dey, L.P. | Stabilized albuterol compositions and method of preparation thereof |
| HU227112B1 (hu) * | 2006-06-14 | 2010-07-28 | Richter Gedeon Nyrt | Ipari eljárás 17-alfa-acetoxi-11-béta-[4-(N,N-dimetil-amino)-fenil]-19-norpregna-4,9-dién-3,20-dion elõállítására és új intermedierek az eljáráshoz |
| PT2805720T (pt) | 2008-05-28 | 2019-09-23 | Reveragen Biopharma Inc | Moduladores esteroides não hormonais de nf-kb para tratamento de uma doença |
| EP2556083A4 (en) | 2010-04-05 | 2013-12-04 | Validus Biopharma Inc | NONHORMONAL STEROID MODULATORS OF NF-KAPPA-B FOR DISEASE TREATMENT |
| CN102477060B (zh) * | 2010-11-22 | 2014-08-13 | 华润紫竹药业有限公司 | 甾体化合物及其制备方法和用途 |
| CN104093732A (zh) | 2011-12-23 | 2014-10-08 | 晶体制药独资有限公司 | 炔基化16-取代-17-酮基类固醇的方法 |
| CN104628806A (zh) * | 2012-01-19 | 2015-05-20 | 华润紫竹药业有限公司 | 甾体化合物及其制备方法和用途 |
| CN106046099B (zh) * | 2012-01-19 | 2018-03-16 | 华润紫竹药业有限公司 | 甾体化合物及其制备方法和用途 |
| CN102702296B (zh) * | 2012-06-19 | 2014-09-03 | 山东诚创医药技术开发有限公司 | 环-3,20-双(1,2-亚乙基缩醛)-17α-羟基-17β-乙酰基-雌甾-5(10),9(11)-二烯-3-酮的制备方法 |
| CN102942612A (zh) * | 2012-10-30 | 2013-02-27 | 四川大学 | 一种合成醋酸乌利司他的新方法 |
| WO2014067127A1 (zh) * | 2012-11-02 | 2014-05-08 | Huang Yunsheng | 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法 |
| CN103145788B (zh) * | 2013-03-25 | 2015-08-19 | 浙江仙琚制药股份有限公司 | 醋酸优力司特关键中间体的制备方法 |
| US10799514B2 (en) | 2015-06-29 | 2020-10-13 | Reveragen Biopharma, Inc. | Non-hormonal steroid modulators of NF-kappa beta for treatment of disease |
| CN105001294A (zh) * | 2015-07-29 | 2015-10-28 | 宝鸡康乐生物科技有限公司 | 一种妊娠素的合成方法 |
| CN105153261B (zh) * | 2015-10-08 | 2017-12-05 | 浙江仙居君业药业有限公司 | 一种炔孕酮的合成方法 |
| CN106986908B (zh) * | 2017-03-23 | 2019-05-10 | 湖南玉新药业有限公司 | 倍他米松的制备方法 |
| CN106986911B (zh) * | 2017-03-23 | 2019-05-10 | 湖南玉新药业有限公司 | 地塞米松关键中间体联烯亚砜物的制备方法 |
| US11382922B2 (en) | 2019-03-07 | 2022-07-12 | Reveragen Biopharma, Inc. | Aqueous oral pharmaceutical suspension compositions |
| CN112175035A (zh) * | 2020-09-08 | 2021-01-05 | 山东斯瑞药业有限公司 | 一种倍他米松重排物的制备方法及倍他米松重排物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3499016A (en) * | 1958-08-04 | 1970-03-03 | Upjohn Co | 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series |
| US3499013A (en) * | 1968-11-04 | 1970-03-03 | Searle & Co | 3-oxygenated 21beta-hydrocarbonsulfonyl-pregna-17(20),20-dienes,dehydro and 19-nor derivatives thereof and intermediates thereto |
| FR2150216A1 (en) * | 1971-08-20 | 1973-04-06 | Syntex Corp | 17-vinylidene steroids - inters for progesterone derivs |
| US3992422A (en) * | 1975-08-14 | 1976-11-16 | Schering Corporation | Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes |
| US4041055A (en) * | 1975-11-17 | 1977-08-09 | The Upjohn Company | Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes |
-
1975
- 1975-11-17 US US05/632,671 patent/US4041055A/en not_active Expired - Lifetime
-
1976
- 1976-10-04 MX MX764952U patent/MX4328E/es unknown
- 1976-10-27 IL IL50787A patent/IL50787A/xx unknown
- 1976-10-29 DE DE2649753A patent/DE2649753C2/de not_active Expired
- 1976-11-02 GB GB9335/78A patent/GB1531048A/en not_active Expired
- 1976-11-02 GB GB9337/78A patent/GB1531050A/en not_active Expired
- 1976-11-02 GB GB45413/76A patent/GB1531047A/en not_active Expired
- 1976-11-02 GB GB9336/78A patent/GB1531049A/en not_active Expired
- 1976-11-03 CH CH1388676A patent/CH636362A5/fr not_active IP Right Cessation
- 1976-11-08 NL NLAANVRAGE7612364,A patent/NL170420C/xx not_active IP Right Cessation
- 1976-11-11 JP JP51134735A patent/JPS5262265A/ja active Granted
- 1976-11-16 PL PL1976215854A patent/PL119050B1/pl unknown
- 1976-11-16 PL PL1976214253A patent/PL116356B1/pl unknown
- 1976-11-16 PL PL1976193723A patent/PL116459B1/pl unknown
- 1976-11-16 FR FR7634507A patent/FR2351997A1/fr active Granted
- 1976-11-17 HU HU76UO127A patent/HU178128B/hu unknown
- 1976-11-17 IE IE2537/76A patent/IE44548B1/en unknown
- 1976-11-17 HU HU76UO130A patent/HU174396B/hu unknown
- 1976-11-17 HU HU812029A patent/HU188067B/hu unknown
- 1976-11-17 HU HU76UO157A patent/HU177914B/hu unknown
- 1976-11-17 HU HU@@A patent/HU173541B/hu unknown
- 1976-11-17 HU HU812028A patent/HU188066B/hu unknown
- 1976-11-17 HU HU76UO129A patent/HU173670B/hu unknown
- 1976-11-17 HU HU76UO158A patent/HU178129B/hu unknown
-
1977
- 1977-08-05 FR FR7724254A patent/FR2366310A1/fr active Granted
-
1979
- 1979-10-23 IL IL58540A patent/IL58540A0/xx unknown
- 1979-10-23 IL IL58539A patent/IL58539A0/xx unknown
-
1980
- 1980-12-03 CH CH894180A patent/CH630394A5/de not_active IP Right Cessation
-
1986
- 1986-11-06 JP JP61262901A patent/JPS6354393A/ja active Granted
- 1986-11-06 JP JP61262903A patent/JPS6354391A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2146334A (en) * | 1981-05-18 | 1985-04-17 | Upjohn Co | Steroid 21-sulfoxides |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1531047A (en) | Steroid sulphoxides and their preparation | |
| GB1475795A (en) | Steroid 21-thioesters | |
| Sheehan et al. | The total synthesis of a 5-phenyl penicillin: Methyl 5-phenyl-(2-carbomethoxyethyl)-penicillinate | |
| DE68911157D1 (de) | Synthese von 6-Methylenandrosta-1,4-dien-3,17-dion-Derivate. | |
| WO1987007605A1 (fr) | Nouveaux derives de biphenyle, procede pour leur preparation, et leur utilisation | |
| GB1382917A (en) | Indole derivatives | |
| GB1510841A (en) | Derivatives of 11-hydroxytestosterone processes for preparing them and uses for them | |
| GB1458629A (en) | 2,3-dihydrobenzofuranyl-7-n-methylcarbamates their preparation and their use as insecticides | |
| GB1514111A (en) | 3alpha,5alpha-cyclo-6beta-alkoxy-25-hydroxy-steroid derivatives and their preparation | |
| ES477161A1 (es) | Procedimiento para la preparacion de esteroides. | |
| GB1461051A (en) | Bufatrienolide rhamnoside ethers and a process for their preparation | |
| GB1458517A (en) | 21-sulphinyl steroids | |
| GB1463850A (en) | 4-deoxy-4-oxoerythromycin b derivatives | |
| GB1277266A (en) | 07-acetylgonanes and derivatives therefor | |
| GB1530837A (en) | 3beta-(1-alkoxyethoxy)-steroids and their use in the production of steroids from sarsaponin | |
| GB1450807A (en) | Cardenolide glycosides and process for their manufacture | |
| GB1578065A (en) | Process for the production of pregnane derivatives | |
| CA1202299A (en) | 3-chloropregnane derivatives and a process for preparing same | |
| IE42468L (en) | 13-ethynyl- and 13-(2 halovinyl)-steroids | |
| GB1141236A (en) | Improvements in or relating to the synthesis of cyanohydrins | |
| GB1323775A (en) | Cardenolide-and bufadienolide-3-2,3-didesoxyglycosides and processes for their preparation | |
| GB1499823A (en) | 3,20-dione-1,4,9(11)-triene steroids | |
| GB1492446A (en) | 4,5-secopregnane derivatives | |
| GB1432379A (en) | Preparation of quinoline derivatives | |
| FR2400526A2 (fr) | Procede de preparation de 3a, 5a-cyclo-6b-alkoxy-d22-25-oxy- ou -acyloxy-bisnorcholestanes et analogues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |